At the heart of Prosarix's technology is ProtoDiscovery™, an advanced computational drug discovery platform for use in the identification and optimisation of small molecule ligands to specific targets. The platform contains a number of applications that can be used independently or as part of a workflow for either structure-based or ligand-based projects.
ProtoDiscovery™ contains three structure-based technologies:
ProtoDiscovery™ contains two ligand-based technologies:
To support any computational screening work Prosarix has assembled and maintains the PCD, a virtual compound library:
Other ProtoDiscovery™ tools include:
These tools, together with other industry standard applications such as the Chemical Computing Group’s MOE software, enable Prosarix to operate a significant computational resource for both in-house operations and external projects.